Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-11-01
2005-11-01
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S560000, C514S004300, C530S303000, C530S304000
Reexamination Certificate
active
06960561
ABSTRACT:
The invention relates to a formulation comprising a polypeptide selected from at least one of insulin, an insulin metabolite, an insulin analog, and an insulin derivative; at least one surfactant; optionally at least one preservative; and optionally at least one of an isotonicizing agent, a buffer or an excipient, wherein the formulation is free from or low in zinc. The invention also relates to the production of such insulin preparations and their use as pharmaceutical formulations.
REFERENCES:
patent: 4153689 (1979-05-01), Hirai et al.
patent: 5506203 (1996-04-01), Bäckström et al.
patent: 6211144 (2001-04-01), Havelund
patent: 0 166 529 (1986-01-01), None
patent: 0 200 383 (1986-12-01), None
patent: 0 200 383 (1986-12-01), None
patent: WO 98/42749 (1998-10-01), None
patent: WO 98/42749 (1998-10-01), None
patent: WO 00/74736 (2000-12-01), None
patent: WO 00/074736 (2002-08-01), None
H. Thurow and K. Geisen, “Stabilisation of dissolved proteins against denaturation at hydrophobic interfaces,”Diabetologia, 27:212-18 (1984).
W.D. Lougheed et al., “Physical Stability of Insulin Formulations,”Diabetes, 32: 424-32 (1983).
Aventis Pharma Deutschland GmbH
Chism B. Dell
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Tate Christopher R.
LandOfFree
Zinc-free and low-zinc insulin preparations having improved... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Zinc-free and low-zinc insulin preparations having improved..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Zinc-free and low-zinc insulin preparations having improved... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3461173